Join Beneva's October webinar to gain insights into the clinical, financial and workplace dimensions of neurological conditions
As employee health challenges grow more complex, employers are keen to adapt to the shifting needs. Conditions like ADHD, migraines, and early-onset Alzheimer’s are showing up more often in the workforce, driving absenteeism, presenteeism, and drug claims. At the same time, breakthrough therapies for these conditions are delivering hope but at a cost that can sometimes overwhelm benefit plans.
Access to mental health support, digital service delivery, and thoughtful plan design are now essential to keeping programs sustainable. The encouraging sign is that most employers continue to treat health benefits as something worth protecting. What they need are smarter ways to balance employee support with financial responsibility.
Beneva’s upcoming Oct. 2 webinar will provide an integrated view of the clinical, financial, and workplace dimensions of neurological conditions, along with forward-looking strategies to contain costs without cutting value.
The rising cost of care
New pharmaceutical therapies for neurological conditions can be life-changing, but they often carry a price tag that can quickly overwhelm a benefits plan. Specialty drugs are among the fastest-growing cost drivers in group insurance. Left unmanaged, they risk crowding out other areas of care.
Industry experts argue that the way forward is not to cut back but to think differently about support. That means bringing clinical insight, workplace strategies, and financial expertise together.
Proactive approaches can make a measurable difference:
- Raising awareness of neurological conditions so employees can be supported before challenges escalate.
- Updating workplace policies to create more flexible and inclusive environments for neurodiverse employees.
- Monitoring drug trends to anticipate cost pressures on plan budgets.
- Using tools such as biosimilar transitions, prior authorization, and specialty drug programs to contain costs without reducing access to care
For advisors, this also means broadening conversations with clients. Beyond simply addressing coverage needs advisors can play a key role in helping employers understand how conditions like ADHD, migraines, and Alzheimer’s affect workplace operations, culture, and retention.
Perspectives from Beneva
Frances Lehun, pharmacist at Beneva, will share insight into pharmaceutical trends and the realities of high-cost drug management
Sunil Hirjee, Vice President of Sales and Partner Experience, Ontario, Western and Atlantic region at Beneva, has over 25 years of experience in financial services and will discuss how organizations can adapt benefit strategies to reflect evolving employee and workplace needs
Valerie Fernandez, Senior Advisor in Workplace Health Solutions, brings nearly 20 years of experience in workplace wellness. A Université Laval-trained kinesiologist, she supports employers in prevention, attendance management, and culture-building, with a passion for early intervention and practical supports.
What to expect
The webinar will leave participants with:
- A clearer understanding of how neurological conditions can impact productivity, absenteeism, and benefit costs
- Insight into the emerging drug trends that place pressure on plan sustainability
- Practical ways for advisors and employers to balance cost with care
Neurological conditions are not going away. They are becoming more prevalent, more costly, and more central to how organizations think about health. This conversation is about more than managing risk. Register here to gain access to Beneva’s webinar.
